Brief: Isofol Medical Q4 Loss For Period Widens To SEK 61.2 Mln
Feb 24 (Reuters) - Isofol Medical AB (publ) ISOFOL.ST :
* ISOFOL MEDICAL AB (PUBL) PUBLISHES YEAR-END REPORT,
JANUARY -
DECEMBER 2021
* Q4 NET REVENUE AMOUNTED TO TSEK 4,704 (18,680)
* Q4 RESULT FOR PERIOD AMOUNTED TO TSEK -61,170 (-54,659)
* BOARD OF DIRECTORS PROPOSES THAT NO DIVIDEND WILL BE PAID
FOR
2021 FINANCIAL YEAR
Source text for Eikon: ID:nWkrbthMTQ
Further company coverage: ISOFOL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Isofol Medical AB (publ)
See all newsSweden's Isofol Medical Q1 net loss widens, raises funds
Brief: Isofol Medical Q1 Net Income SEK -15.062 Million
Brief: Isofol Medical Announces Bfarm Approval Of Optimized Phase Ib/Ii Study Design
Brief: Isofol Gets Gross Proceeds Of SEK 18.9 Mln In Connection With Exercise Of Warrants And Guarantee Commitments
Brief: Isofol Secures License Rights For Arfolitixorin In Autism